Human Papillomavirus (HPV): Integrating Oral Health for Prevention

HPV is one of the world’s most widespread viral infections and a major cause of cervical and oral cancers and related conditions. Despite its broad impact, HPV prevention is rarely integrated into oral healthcare, leaving gaps in awareness, early detection, and referral. 

This project addresses the problem by strengthening global HPV prevention and calling for the inclusion of oral health professionals in national policies and care pathways. 

Project goals

  • Drive advocacy efforts to strengthen the role of oral health professionals in HPV prevention.
     
  • Develop policy recommendations to integrate HPV prevention into oral health services.

Guided by insights from FDI’s multi-country survey, the project will drive policy alignment, build professional capacity through evidence-based education, and create targeted resources that support vaccination, early detection, and coordinated cancer prevention strategies.

Image
fdi project HPV
Image
FDI White Paper - HPV

White Paper – Integrating oral health professionals into HPV prevention

The goal of this white paper is to provide OHPs with updated, evidence-based FDI guidance and tools on the prevention and detection of HPV-associated OPSCC. It is intended to complement, not replace, existing clinical guidance. By recognizing OHPs as important partners in HPV prevention, policymakers, healthcare systems, and initiatives can help close the current gaps in prevention, public awareness and vaccine uptake to reduce the future burden of HPV-associated OPSCC.

Download the white paper

Human Papillomavirus (HPV) Task Team

Chair
Sep 2025 - Sep 2026
Dr Nisha D’Silva
United States of America
Member
Sep 2025 - Sep 2026
Dr Doniphan Hammer
France
Member
Sep 2025 - Sep 2026
Prof. Kivanç Bektas Kayhan
Türkiye
Member
Sep 2025 - Sep 2026
Prof. Katalin Nagy
Hungary

The HPV project is supported by a grant from:

Image
MSD

MSD (Merck & Co., known as MSD outside the United States and Canada)